Mycobutin (Rifabutin)

Rifabutin, the active ingredient in Mycobutin, is a rifamycin antibiotic presented as an oral tablet for oral use. It treats Mycobacterium avium complex infections, provides prophylaxis in HIV‑positive patients, and is used in tuberculosis therapy, including resistant strains.

GNH USA supplies Mycobutin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Rifabutin is indicated for infections caused by mycobacteria and is employed within the antitubercular therapeutic pathway.

- Mycobacterium avium complex (MAC) infection: reduces bacterial load and helps prevent disease progression. - Prophylaxis of MAC in HIV‑positive patients: lowers the risk of opportunistic MAC disease. - Tuberculosis (including resistant strains): contributes to bacterial eradication as part of combination therapy.

Rifabutin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Vomiting - Abdominal pain - Diarrhea - Rash - Fever

Serious or Rare Side Effects: - Neutropenia - Hepatotoxicity - Severe hypersensitivity reactions - Thrombocytopenia - Hemolytic anemia - Interstitial pneumonitis

Before initiating therapy, several safety considerations should be reviewed.

- Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic dysfunction: assess liver enzymes regularly. - Concurrent HIV therapy: evaluate potential drug‑drug interactions. - Pregnancy: use only when potential benefits outweigh risks. - Lactation: avoid unless clearly indicated. - Store at ambient temperature: keep in original container, protect from moisture and light.

Rifabutin interacts with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Protease inhibitors (e.g., ritonavir): may markedly increase rifabutin concentrations. - Macrolide antibiotics (e.g., clarithromycin, azithromycin): can raise toxicity risk. - Anticonvulsants (e.g., carbamazepine, phenytoin): may reduce rifabutin efficacy.

Moderate Interactions (Monitor Closely): - Antiretroviral agents (e.g., efavirenz): may alter rifabutin levels. - Warfarin: may increase INR and bleeding risk. - Oral contraceptives: may reduce hormonal effectiveness.